These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3096709)

  • 21. High dietary retinoic acid inhibits tumor promotion and malignant conversion in a two-stage skin carcinogenesis protocol using 7,12-dimethylbenz[a]anthracene as the initiator and mezerein as the tumor promoter in female SENCAR mice.
    Chen LC; Tarone R; Huynh M; De Luca LM
    Cancer Lett; 1995 Aug; 95(1-2):113-8. PubMed ID: 7656218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin E is a complete tumor promoter in mouse skin.
    Mitchel RE; McCann R
    Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2) F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement.
    Naito M; Chenicek KJ; Naito Y; DiGiovanni J
    Carcinogenesis; 1988 Apr; 9(4):639-45. PubMed ID: 3128409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further studies on the influence of initiation dose on papilloma growth and progression during two-stage carcinogenesis in SENCAR mice.
    DiGiovanni J; Walker SE; Aldaz CM; Slaga TJ; Conti CJ
    Carcinogenesis; 1993 Sep; 14(9):1831-6. PubMed ID: 8403206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution, covalent binding, and DNA adduct formation of 7,12-dimethylbenz(a)anthracene in SENCAR and BALB/c mice following topical and oral administration.
    Morse MA; Baird WM; Carlson GP
    Cancer Res; 1987 Sep; 47(17):4571-5. PubMed ID: 2441852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter independence as a feature of most skin papillomas in SENCAR mice.
    Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
    Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the inhibitory effects of retinoids on 12-O-tetradecanoylphorbol-13-acetate-promoted tumor formation in CD-1 and Sencar mice.
    Dawson MI; Chao WR
    Cancer Lett; 1988 May; 40(1):7-12. PubMed ID: 3130981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
    Reiners JJ; Pavone A; Rupp T; Cantu AR
    Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
    J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
    Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
    Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion.
    Birt DF; Pelling JC; Anderson J; Barnett T
    Carcinogenesis; 1994 Oct; 15(10):2341-5. PubMed ID: 7955075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice.
    Wei H; Bowen R; Zhang X; Lebwohl M
    Carcinogenesis; 1998 Aug; 19(8):1509-14. PubMed ID: 9744550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.
    Nesnow S; Bergman H; Slaga TJ
    Environ Health Perspect; 1986 Sep; 68():19-25. PubMed ID: 3780628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and initial characterization of several new inbred strains of SENCAR mice for studies of multistage skin carcinogenesis.
    Coghlan LG; Gimenez-Conti I; Kleiner HE; Fischer SM; Rundhaug JE; Conti CJ; Slaga TJ; DiGiovanni J
    Carcinogenesis; 2000 Apr; 21(4):641-6. PubMed ID: 10753198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative events and DNA damage.
    Wei L; Wei H; Frenkel K
    Carcinogenesis; 1993 May; 14(5):841-7. PubMed ID: 8389253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to two-stage carcinogenesis of SENCAR mouse skin grafted to nude mice.
    Yuspa SH; Spangler EF; Donahoe R; Geusz S; Ferguson E; Wenk M; Hennings H
    Cancer Res; 1982 Feb; 42(2):437-9. PubMed ID: 6799187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor initiating activity of 9- and 10-fluoro-7,12-dimethylbenz[a]-anthracene (DMBA) and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on tumor initiation by monofluoro derivatives of DMBA in SENCAR mice.
    DiGiovanni J; Decina PC; Diamond L
    Carcinogenesis; 1983 Aug; 4(8):1045-9. PubMed ID: 6409443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivity of fecapentaene-12 as a rodent carcinogen or tumor initiator.
    Ward JM; Anjo T; Ohannesian L; Keefer LK; Devor DE; Donovan PJ; Smith GT; Henneman JR; Streeter AJ; Konishi N
    Cancer Lett; 1988; 42(1-2):49-59. PubMed ID: 3141039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.